WallStSmart
RCKT

Rocket Pharmaceuticals Inc

NASDAQ: RCKT · HEALTHCARE · BIOTECHNOLOGY

$3.48
+0.00% today

Updated 2026-04-30

Market cap
$384.11M
P/E ratio
P/S ratio
EPS (TTM)
$-2.01
Dividend yield
52W range
$2 – $8
Volume
3.7M

Rocket Pharmaceuticals Inc (RCKT) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+3.3%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+38.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-4.4%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-4.5%
2025-11-06
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-02$-0.38+11.2%$5.01$4.80-4.2%
2025-11-06$-0.45+8.2%$3.32$3.17-4.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.43$-0.38+11.2%
2025-09-30$-0.49$-0.45+8.2%
2025-06-30$-0.56$-0.62-10.3%
2025-03-31$-0.58$-0.56+4.0%
2024-12-31$-0.72$-0.62+13.6%$9.19M-10.9%
2024-09-30$-0.76$-0.71+6.6%
2024-06-30$-0.72$-0.74-2.8%
2024-03-31$-0.68$-0.66+2.9%
2023-12-31$-0.79$-0.64+19.0%$10.31M
2023-09-30$-0.81$-0.75+7.4%
2023-06-30$-0.79$-0.82-3.8%
2023-03-31$-0.85$-0.73+14.1%

Frequently asked questions

Has Rocket Pharmaceuticals Inc beaten earnings estimates?
Rocket Pharmaceuticals Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +3.3% over the last 4 quarters.
How does RCKT stock react to earnings?
RCKT stock has moved an average of -4.4% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.